The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goyal Vikas since 2017.
This trader's CIK number is 1721017.
At the time of last reporting, Goyal Vikas was the Director of Morphic Holding, Inc.. (stock ticker symbol MORF).
Also see all insider trading activities at Morphic Holding, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | MORF | 1,000 | $70,000 | 0 | $0 | 0 | $0 |
| 2019 | MORF | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | SPRO | 428,571 | $5,999,994 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | PAND | 1,450 | $26,100 | 0 | $0 | 0 | $0 |
1. Morphic Holding, Inc. (MORF)
2. Spero Therapeutics, Inc. (SPRO)
3. Pandion Therapeutics, Inc. (PAND)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-05 | MORF | Buy | 1,000 | 70.00 | 70,000 |
| 2019-07-01 | MORF | Buy | 333,333 | 15.00 | 4,999,995 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-06 | SPRO | Buy | 428,571 | 14.00 | 5,999,994 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-21 | PAND | Buy | 1,450 | 18.00 | 26,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goyal Vikas (Director of Morphic Holding, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.